Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

The drug JNJ-5939 was being evaluated in the treatment of moderate to severe atopic dermatitis in a mid-stage study. ・JNJ, ...

On December 26, Johnson & Johnson (NYSE:JNJ) said it ended a mid-stage study of an experimental drug for patients with ...

In spite of its commonality, there are still plenty of unknowns around atopic dermatitis, including the actual cause of the skin condition. Perhaps that’s why there are so many myths surrounding it.

The company said the results of a planned interim analysis met prespecified criteria for early termination of the study. "They did not meet the high-bar efficacy we established for advancing our ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published in Nutrients.

Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate ...

Share on Pinterest A new study finds high amounts of dietary sodium are linked to worse eczema symptoms. urbazon/Getty Images A recent study investigates whether sodium intake might influence atopic ...

Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...

You may be able to avoid eczema flare-ups by avoiding triggers. Other tips may include regularly moisturizing your skin and lowering your stress levels. Atopic dermatitis (AD), also known as eczema, ...

Experts break down the most important facts about atopic dermatitis on the hands, including risk factors, treatments, and tips for soothing relief. Atopic dermatitis (AD), the most common form of ...